|
Field
Experimental Design (Public)
|
Before
1.Pure control
2A.Self-affirmations, individual
2B.Self-affirmations, group
3A.Aspirations, individual
3B.Aspirations, group
4A.Placebo, individual
4B.Placebo, group
1.Pure control (respondents not being treated and in villages with no treatment): 16 villages, 35 per village, 560 total
a.NB: not surveyed at baseline or for concluding questionnaire but surveyed for endline
2.Self-affirmations individual: 24 villages, expected to originally treat 30 per village. 574 Actual Respondents Baselined total.
3.Self-affirmations group: 24 villages, expected to originally treat 30 per village. 621 total Actual Respondents Baselined total.
4.Aspirations individual: 24 villages, expected to originally treat 30 per village. 625 total Actual Respondents Baselined total.
5.Aspirations group: 24 villages, expected to originally treat 30 per village. 622 total Actual Respondents Baselined total.
6.Placebo individual: 24 villages, expected to originally treat 30 per village. 570 total Actual Respondents Baselined total.
Placebo group: 24 villages, expected to originally treat 30 per village. 622 total Actual Respondents Baselined total.
|
After
1.Pure control
2A.Self-affirmations, individual
2B.Self-affirmations, group
3A.Aspirations, individual
3B.Aspirations, group
4A.Placebo, individual
4B.Placebo, group
|